-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$9.001068.83% Upside
Omega Therapeutics, Inc. Frequently Asked Questions
-
What analysts cover Omega Therapeutics, Inc.?
Omega Therapeutics, Inc. has been rated by research analysts at Piper Sandler, Loop Capital Markets, H.C. Wainwright in the past 90 days.